MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors

ανά Sells, Todd B., Chau, Ryan, Ecsedy, Jeffrey A., Gershman, Rachel E., Hoar, Kara, Huck, Jessica, Janowick, David A., Kadambi, Vivek J., LeRoy, Patrick J., Stirling, Matthew, Stroud, Stephen G., Vos, Tricia J., Weatherhead, Gabriel S., Wysong, Deborah R., Zhang, Mengkun, Balani, Suresh K., Bolen, Joseph B., Manfredi, Mark G., Claiborne, Christopher F.
Τόπος έκδοσης ACS Med Chem Lett (2015)

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

ανά Manfredi, Mark G., Ecsedy, Jeffrey A., Meetze, Kristan A., Balani, Suresh K., Burenkova, Olga, Chen, Wei, Galvin, Katherine M., Hoar, Kara M., Huck, Jessica J., LeRoy, Patrick J., Ray, Emily T., Sells, Todd B., Stringer, Bradley, Stroud, Stephen G., Vos, Tricia J., Weatherhead, Gabriel S., Wysong, Deborah R., Zhang, Mengkun, Bolen, Joseph B., Claiborne, Christopher F.
Έκδοση 2007